Eddy Ríos-Olivares to Puerto Rico
This is a "connection" page, showing publications Eddy Ríos-Olivares has written about Puerto Rico.
Connection Strength
0.893
-
Maldonado-Mart?nez G, Hunter-Mellado RF, Fern?ndez-Santos D, R?os-Olivares E. Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010050.
Score: 0.095
-
Thompson KJ, R?os-Olivares E. Making a difference: steps to develop a research pipeline in Puerto Rico. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):4-7.
Score: 0.082
-
Cubano LA, Cumba L, del Sep?lveda-Torres LC, Boukli N, R?os-Olivares E. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005. Bol Asoc Med P R. 2010 Jul-Sep; 102(3):13-7.
Score: 0.065
-
R?os G, Mayor AM. Clinical and sociodemographic features of Puerto Ricans with systemic sclerosis. Ethn Dis. 2010; 20(1 Suppl 1):S1-185-9.
Score: 0.063
-
Colon HM, Finlinson HA, Negron J, Sosa I, Rios-Olivares E, Robles RR. Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico. AIDS Behav. 2009 Jun; 13(3):523-31.
Score: 0.060
-
Cubano LA, Sep?lveda-Torres Ldel C, Sosa G, Boukli N, Robles R, Rodriguez JW, Guzm?n L, R?os-Olivares E. Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations. Ethn Dis. 2008; 18(2 Suppl 2):S2-132-6.
Score: 0.055
-
Reyes JC, Col?n HM, Robles RR, Rios E, Matos TD, Negr?n J, Marrero CA, Calder?n JM, Shepard E. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico. J Urban Health. 2006 Nov; 83(6):1105-13.
Score: 0.051
-
Rivera-Matos IR, Rios-Olivares E. A multicenter hospital surveillance of invasive Streptococcus pneumoniae, Puerto Rico, 2001. P R Health Sci J. 2005 Sep; 24(3):185-9.
Score: 0.047
-
Torres Rivera B, Vall?s V, R?os Olivares E. Prevalence of primary and secondary resistant mutations to antiretroviral drug in a population of Puerto Rican infected with HIV. P R Health Sci J. 2002 Dec; 21(4):329-36.
Score: 0.039
-
Roman M, Rodriguez JW, Pag?n NO, Rios-Olivares E, Amill A, Hunter R. Distribution of na?ve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population. P R Health Sci J. 2002 Sep; 21(3):195-201.
Score: 0.038
-
R?os-Olivares E, Yamamura Y, G?mez MA, Guzm?n L, Rodr?guez N, Fern?ndez D, Hunter Mellado R. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections. Cell Mol Biol (Noisy-le-grand). 2001 Sep; 47(6):1017-24.
Score: 0.035
-
Fern?ndez DM, Figueroa WI, G?mez Mde L, Maysonet J, Olivares ER, Hunter RF. Changes in HIV/AIDS knowledge among early adolescents in Puerto Rico. Ethn Dis. 2008; 18(2 Suppl 2):S2-146-50.
Score: 0.027
-
Sep?lveda-Torres LDC, Rishishwar L, Rogers ML, R?os-Olivares E, Boukli N, Jordan IK, Cubano LA. A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011. PLoS One. 2017; 12(5):e0177452.
Score: 0.026
-
Fernandez-Santos DM, Miranda-Diaz C, Figueroa-Cosme WI, Ramon RO, Mayor AM, Rios-Olivares E, Hunter-Mellado RF. Impact of ASUMA Intervention on HIV Risk Behaviors among Puerto Rican Adolescents. Int J Environ Res Public Health. 2015 Dec 23; 13(1):ijerph13010060.
Score: 0.024
-
Ortiz AP, Reyes JC, Palefsky J, Negr?n J, Da Costa M, V?zquez M, Rivera AI, Matos TD, Rios-Olivares E, Tortolero G. Oral human papillomavirus infection among drug users in Puerto Rico. P R Health Sci J. 2014 Dec; 33(4):190-6.
Score: 0.022
-
Maldonado-Mart?nez G, Fern?ndez-Santos DM, R?os-Olivares E, Mayor AM, Hunter-Mellado RF. HIV/AIDS in the Puerto Rican elderly: immunological changes between gender and body mass index. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):94-105.
Score: 0.021
-
Mayor AM, Fern?ndez Santos DM, Dworkin MS, R?os-Olivares E, Hunter-Mellado RF. Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART). Am J Trop Med Hyg. 2011 May; 84(5):838-41.
Score: 0.017
-
Fern?ndez Santos DM, Figueroa-Cosme WI, G?mez Mde L, Maysonet-Cruz J, Miranda-D?az C, Sept?lveda-Santiago M, R?os-Olivares E, Hunter-Mellado RF. Changes in developmental factors and HIV risk behaviors among early adolescents in Puerto Rico. Ethn Dis. 2010; 20(1 Suppl 1):S1-122-6.
Score: 0.016
-
Mayor AM, Dworkin M, Quesada L, R?os-Olivares E, Hunter-Mellado RF. The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico. Ethn Dis. 2010; 20(1 Suppl 1):S1-163-7.
Score: 0.016
-
B?ez Feliciano DV, G?mez MA, Fern?ndez-Santos DM, Quintana R, Rios-Olivares E, Hunter-Mellado RF. Profile of Puerto Rican HIV/AIDS patients with early and non-early initiation of injection drug use. Ethn Dis. 2008; 18(2 Suppl 2):S2-99-104.
Score: 0.014
-
Mayor AM, G?mez MA, R?os-Olivares E, Hunter-Mellado RF. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis. 2008; 18(2 Suppl 2):S2-189-94.
Score: 0.014
-
Mayor AM, Gomez MA, Fernandez DM, Rios-Olivares E, Thomas JC, Hunter RF. Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection. Am J Trop Med Hyg. 2006 Feb; 74(2):239-45.
Score: 0.012
-
B?ez-Feliciano DV, Thomas JC, G?mez MA, Miranda S, Fern?ndez DM, Vel?zquez M, R?os-Olivares E, Hunter-Mellado RF. Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Rev Panam Salud Publica. 2005 Feb; 17(2):92-101.
Score: 0.011
-
Mayor AM, G?mez MA, R?os-Oliveras E, Hunter-Mellado RF. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons. Ethn Dis. 2005; 15(4 Suppl 5):S5-57-62.
Score: 0.011
-
Fern?ndez DM, G?mez Mde L, Figueroa W, Vel?zquez M, B?ez DV, R?os-Olivares E, Hunter RF. A comparison of the sociodemographic, risk-behavior, and substance-abuse profile of young vs older HIV-infected Puerto Rican patients. Ethn Dis. 2005; 15(4 Suppl 5):S5-25-9.
Score: 0.011
-
Mayor AM, Gomez MA, Rios E, Hunter RF. Recurrent pneumonia mortality risk in a HIV/AIDS Puerto Rican cohort. Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1199-204.
Score: 0.010
-
Frame AD, R?os-Olivares E, De Jes?s L, Ortiz D, Pag?n J, M?ndez S. Plants from Puerto Rico with anti-Mycobacterium tuberculosis properties. P R Health Sci J. 1998 Sep; 17(3):243-52.
Score: 0.007
-
Kaplan JE, Yamamura Y, R?os-Olivares EO, Cannon RO, Khabbaz RF, Gubler DJ, Kaiselburd EN, Hartley TM, Lairmore MD. Seroprevalence of human T lymphotropic virus type I in Puerto Rico. Am J Trop Med Hyg. 1989 Jun; 40(6):659-62.
Score: 0.004